{"name":"Prep Biopharm Limited","slug":"prep-biopharm-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNVXpCV25oMmg5aTBBVVZ2cGd1OG9aLUR0aTJJQ2ZHeXQ2TWdHU0gweVlLZ2dXbmVhLXlCaG55X1d2M18yT1J2bk5QbEtXY0JoYWZtbmVrWV96MHVBcW4yOWNaMDhVbWtDTGh1Vkc1UG05em1PaGhVYVRpcFZmbUhCaXBYVU5NcGNXbGljY29fSVUwTzhabmUzSDg3OXk1RS1zc0drUFBPSXJ5WFVyVmZ4RXRVSG92Tk11cFJoVG5sdmFxZTNJdk4wNmQ1VTBGSnNUZ09fbXN4NGpRZEgxYUJzZURPclZ3WnFjNlhaclEwWXBCSGZqdC1QMzNaMXU?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQUlNPckNqcU1yR1N1YVZQOEhoSmRJemVGNnlMOVRnOHZlWjdNaXBrdkdaLUNTb0p1a1ZfdHdCamt0NDJLOFRsVU10UV9FSk1fWlp2VHJaXzl5RUpOVFZlYWlkazItMXJuQmxiSV9iSXBSYlFnd3Z2dndCcTd3alpNc0xYZG1VYXhSN1FEMU9uRk9zekhBTFE?oc=5","date":"2025-06-18","type":"regulatory","source":"BioPharma Dive","summary":"FDA approves twice-yearly shot of Gilead drug for HIV prevention - BioPharma Dive","headline":"FDA approves twice-yearly shot of Gilead drug for HIV prevention","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPOUJYaGNsTXViVEFGTlVZUXFCbUQ5SS1JaGZxNTJiM0JvbGRkdWQ0SDBOdmJ1a3JEVXBEWUxHZWwza25hYnRPa1RqZS1QZFNQOUVoR0h6RjhWU2U2eUNGTlU4THdyYlp1bEtBTDcyNTRtbmt3VlptNGVlRW9Hd000OVVBc3VHYkllUjB0XzFrZkpPU0RpTEdEaFlCTFhqeU0?oc=5","date":"2025-03-05","type":"pipeline","source":"bioprocessintl.com","summary":"Biopharmaceutical developers and manufacturers prep for tariffs and BIOSECURE - bioprocessintl.com","headline":"Biopharmaceutical developers and manufacturers prep for tariffs and BIOSECURE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQSlZHY0xEZ0J4Wjd6SjJ6cUpjX1JmdFlrb2JXUnFOV0pCWGpLbXpCaVhXT0wtSE1XbTdhdXJISmg2RFQwVzN1VkpjSW5hSTFvTXB6WDIzVE50WDR5MmJFM2RaZXZQYml4bnptbXlfRnRoTDZoZ3QyOGhOb2ZVdGs2TEduVnJySDcwT0hfTFVfZGVMXzli?oc=5","date":"2024-10-07","type":"pipeline","source":"BioPharma Dive","summary":"GSK’s ViiV to expand supply of HIV drug in Africa - BioPharma Dive","headline":"GSK’s ViiV to expand supply of HIV drug in Africa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQS0FxUElSQUwtZkNZVmNpeERzZFVnMElfUElndUI0bWtMSEFsdjEyQ0lfTUdOOVZHZkh3ZlZrd3dvdlFaN2hIQ0IyRDBBaWsxeG9nNk5VSHFFaUdQSlYxNElGdmJ3QTJOeTJrLUxpelZnaFpUamMwalBrRXFfRWE5U241R2JoODJORDdaNkZRS1JfTUxNMktEdGFn?oc=5","date":"2024-05-06","type":"pipeline","source":"BioPharma Dive","summary":"Bluebird, Vertex prep for first commercial use of sickle cell gene therapies - BioPharma Dive","headline":"Bluebird, Vertex prep for first commercial use of sickle cell gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPeFlDdk5WV0M3NEc1QlpfZ2YxbDdaS3ZtVGtxRlI5dmJoaTVXUTRzbmhCc250c0tRa3kzN05Zd1pycF9aYkJhZ0FYeVNuX04tU29GMHQxUVk5SWRJY1FJaFFDX2lnLVVvN2cwdlE4eDZNRzh3a3pwNHo1dDI5QlN5ajl0aExaVTBEMHNwOXJrc0dIaER6OURvQVBDZ2hPc04tVXBER2J2cmh2bnRVdzRCdw?oc=5","date":"2023-06-20","type":"pipeline","source":"BioSpace","summary":"Will US Pharma See Lawsuits over COVID Vaccine Side Effects? - BioSpace","headline":"Will US Pharma See Lawsuits over COVID Vaccine Side Effects?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQbnFfbDU2Vlc0ZW9BcnItOVEta2p2eVBmM3FaaFFERG5CS0tRd2JBd2ZtWXNOd0lXMEZYNG55LS1SaF82T3ltWDFnV2JVQmQzODJjT0RHSGdDOS1LcGJzemZzV2I2cjI1NnVEV0FFSFBKQXhVT05xZlhQQmxWMGNzTjYyOUtnUHczRGdCaTlCQjdjZ3FpbTZyaXZDdktWeWVKc09feVNtbVc5bEVGS09PR29ZSk52Z0t3UkhvbHFDZ2UtWHh3YklxYk45RUo3c1UtOUVZX0FILVozU1MzZTFfREZaYmo1dw?oc=5","date":"2022-08-31","type":"pipeline","source":"prnewswire.com","summary":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - prnewswire.com","headline":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPQUhvTFNXQjhGamg0a0ljQzc2UEtLU1hYTUMxb2ZrdVVWbU4yMDQ5MUVVeHZ1TVc3aVMxV0FrSE5vRUZIbE5EdWlyODdrcHF5YlZzcloyQ0pMM0xlVU1lR3c5Sm02ekswQ2kwb19HTnRGVHdJZ1pOV2RuOTN1ZnNGYnlsdTU2YVZfRHFwd2RVOWVuNzJ4MG12OER3M09waEVmT1ROMUl3RDNaZHFrZDRKMTZaZXhNVkwzZnZaVGxkTkpOQVFKT09GRkZoaFN1d2xnME1mNGhWdlIzejBxTmNvWDlteHRsWlVz?oc=5","date":"2022-02-21","type":"pipeline","source":"GlobeNewswire","summary":"Toll-Like Receptor Agonist Pipeline Insights | Research Report 2022 by DelveInsight - GlobeNewswire","headline":"Toll-Like Receptor Agonist Pipeline Insights | Research Report 2022 by DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZEpMSlpDLUJCNE1pakVJTHpvSy0tRmVfSjRtdzgxTEhhaTR0ZDh3RU1pSER5cEVrYmc5V0Exc1lYT2h0bjJINFZVUmFoRTBORnhaREdVVE5tQnl3T3FkUmVLZVgtb29Makdsd1RpYUhLMnd0RkhQVC00dnoxamg3eHZSb29oQzRFalUySmJHVU5FOTBBX09hallfdVVYZ2JJaTRCYzlqaXo5aldra0NJQ1JFUDRxekFkbjhjN2ZocWh1Um5rY1JVZQ?oc=5","date":"2020-07-01","type":"pipeline","source":"BioPharm International","summary":"Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow - BioPharm International","headline":"Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}